BMO Capital analyst Amit Sharma is keeping his Outperform rating and $34 price target on Keurig Dr Pepper (KDP), citing its expected "sector leading" mid-teen earnings growth through 2021 along with his "greater confidence" in post-synergies earnings growth potential in high single digits. The analyst notes that investors are focusing on the company's coffee business while overlooking the "ingrained structural advantages" of its much-larger RTD beverage business, with consensus estimates modeling a "smaller" improvement than the expected North America sales trends at Coca-Cola (KO) and PepsiCo (PEP).

JPMorgan lowered the firm's price target on Coca-Cola to $65 from $66 and keeps an Overweight rating on the shares ahead of the Q1 report. The analyst sees a favorable setup for 2024, but is more cautious on volumes in Q1 versus the Street and is not expecting a guidance raise.